Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ning Ren

Showing results (241-250 of 312) with videos related to

Pageof 32
Sort By:
American Journal of Cancer Research|October 12, 2020
High RPS3A expression correlates with low tumor immune cell infiltration and unfavorable prognosis in hepatocellular carcinoma patientsChenhao Zhou, Jialei Weng, Chunxiao Liu, et al.
Oncotarget|December 20, 2017
Long non-coding RNA00364 represses hepatocellular carcinoma cell proliferation via modulating p-STAT3-IFIT2 signaling axisWei-Guo Tang, Bo Hu, Hai-Xiang Sun, et al.
Journal of Cancer Research and Clinical Oncology|June 21, 2006
The prognostic significance of preoperative plasma levels of osteopontin in patients with hepatocellular carcinomaHui Zhang, Qing-Hai Ye, Ning Ren, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 9, 2014
Quantitative assessment of the effect of glutathione S-transferase genes GSTM1 and GSTT1 on hepatocellular carcinoma riskYing-Hao Shen, Si Chen, Yuan-Fei Peng, et al.
Molecular Ecology|January 17, 2024
Genetic architecture of ecological divergence between Oryza rufipogon and Oryza nivaraQing-Lin Meng, Cheng-Gen Qiang, Ji-Long Li, et al.
Cancer Letters|October 14, 2009
Interferon alpha inhibits hepatocellular carcinoma growth through inducing apoptosis and interfering with adhesion of tumor endothelial cellsTi Zhang, Hui-Chuan Sun, Hong-Yuan Zhou, et al.
Clinical Immunology (Orlando, Fla.)|September 17, 2023
MAIT cells confer resistance to Lenvatinib plus anti-PD1 antibodies in hepatocellular carcinoma through TNF-TNFRSF1B pathwayCheng Zhou, Bao-Ye Sun, Pei-Yun Zhou, et al.
Frontiers in Oncology|December 12, 2022
Lenvatinib plus anti-PD-1 therapy represents a feasible conversion resection strategy for patients with initially unresectable hepatocellular carcinoma: A retrospective studyYong Yi, Bao-Ye Sun, Jia-Lei Weng, et al.
BMC Plant Biology|November 29, 2023
Identification of WUSCHEL-related homeobox gene and truncated small peptides in transformation efficiency improvement in EucalyptusZhuo-Ao Zhang, Mei-Ying Liu, Shu-Ning Ren, et al.
Redox Biology|March 26, 2021
Quiescin sulfhydryl oxidase 1 promotes sorafenib-induced ferroptosis in hepatocellular carcinoma by driving EGFR endosomal trafficking and inhibiting NRF2 activationJialei Sun, Chenhao Zhou, Yue Zhao, et al.
Pageof 32

Showing results (241-250 of 312) with videos related to

Sort By:
Pageof 32
American Journal of Cancer Research|October 12, 2020
High RPS3A expression correlates with low tumor immune cell infiltration and unfavorable prognosis in hepatocellular carcinoma patientsChenhao Zhou, Jialei Weng, Chunxiao Liu, et al.
Oncotarget|December 20, 2017
Long non-coding RNA00364 represses hepatocellular carcinoma cell proliferation via modulating p-STAT3-IFIT2 signaling axisWei-Guo Tang, Bo Hu, Hai-Xiang Sun, et al.
Journal of Cancer Research and Clinical Oncology|June 21, 2006
The prognostic significance of preoperative plasma levels of osteopontin in patients with hepatocellular carcinomaHui Zhang, Qing-Hai Ye, Ning Ren, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 9, 2014
Quantitative assessment of the effect of glutathione S-transferase genes GSTM1 and GSTT1 on hepatocellular carcinoma riskYing-Hao Shen, Si Chen, Yuan-Fei Peng, et al.
Molecular Ecology|January 17, 2024
Genetic architecture of ecological divergence between Oryza rufipogon and Oryza nivaraQing-Lin Meng, Cheng-Gen Qiang, Ji-Long Li, et al.
Cancer Letters|October 14, 2009
Interferon alpha inhibits hepatocellular carcinoma growth through inducing apoptosis and interfering with adhesion of tumor endothelial cellsTi Zhang, Hui-Chuan Sun, Hong-Yuan Zhou, et al.
Clinical Immunology (Orlando, Fla.)|September 17, 2023
MAIT cells confer resistance to Lenvatinib plus anti-PD1 antibodies in hepatocellular carcinoma through TNF-TNFRSF1B pathwayCheng Zhou, Bao-Ye Sun, Pei-Yun Zhou, et al.
Frontiers in Oncology|December 12, 2022
Lenvatinib plus anti-PD-1 therapy represents a feasible conversion resection strategy for patients with initially unresectable hepatocellular carcinoma: A retrospective studyYong Yi, Bao-Ye Sun, Jia-Lei Weng, et al.
BMC Plant Biology|November 29, 2023
Identification of WUSCHEL-related homeobox gene and truncated small peptides in transformation efficiency improvement in EucalyptusZhuo-Ao Zhang, Mei-Ying Liu, Shu-Ning Ren, et al.
Redox Biology|March 26, 2021
Quiescin sulfhydryl oxidase 1 promotes sorafenib-induced ferroptosis in hepatocellular carcinoma by driving EGFR endosomal trafficking and inhibiting NRF2 activationJialei Sun, Chenhao Zhou, Yue Zhao, et al.
Pageof 32